Barclays’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-190,332
Closed -$4.5M 4326
2023
Q4
$4.5M Buy
190,332
+146,694
+336% +$3.47M ﹤0.01% 1567
2023
Q3
$651K Sell
43,638
-10,603
-20% -$158K ﹤0.01% 2381
2023
Q2
$594K Buy
54,241
+27,265
+101% +$299K ﹤0.01% 2489
2023
Q1
$236K Sell
26,976
-20,799
-44% -$182K ﹤0.01% 3054
2022
Q4
$300K Buy
47,775
+42,722
+845% +$268K ﹤0.01% 2891
2022
Q3
$18K Sell
5,053
-129,900
-96% -$463K ﹤0.01% 3982
2022
Q2
$398K Buy
134,953
+93,054
+222% +$274K ﹤0.01% 2733
2022
Q1
$130K Sell
41,899
-42,228
-50% -$131K ﹤0.01% 3557
2021
Q4
$285K Buy
84,127
+55,795
+197% +$189K ﹤0.01% 2729
2021
Q3
$104K Buy
28,332
+19,348
+215% +$71K ﹤0.01% 3206
2021
Q2
$40K Sell
8,984
-49,330
-85% -$220K ﹤0.01% 3483
2021
Q1
$264K Buy
58,314
+35,694
+158% +$162K ﹤0.01% 3012
2020
Q4
$129K Sell
22,620
-9,119
-29% -$52K ﹤0.01% 2886
2020
Q3
$230K Sell
31,739
-87,062
-73% -$631K ﹤0.01% 2666
2020
Q2
$415K Sell
118,801
-19,218
-14% -$67.1K ﹤0.01% 2428
2020
Q1
$204K Buy
138,019
+62,598
+83% +$92.5K ﹤0.01% 2533
2019
Q4
$149K Sell
75,421
-727,331
-91% -$1.44M ﹤0.01% 3306
2019
Q3
$4.11M Buy
802,752
+401,778
+100% +$2.06M ﹤0.01% 1203
2019
Q2
$2.87M Buy
400,974
+337,927
+536% +$2.42M ﹤0.01% 1508
2019
Q1
$837K Buy
63,047
+59,700
+1,784% +$793K ﹤0.01% 2284
2018
Q4
$26K Sell
3,347
-52,933
-94% -$411K ﹤0.01% 3325
2018
Q3
$624K Buy
56,280
+51,957
+1,202% +$576K ﹤0.01% 2532
2018
Q2
$58K Sell
4,323
-84,064
-95% -$1.13M ﹤0.01% 3256
2018
Q1
$1.15M Sell
88,387
-49,173
-36% -$639K ﹤0.01% 1698
2017
Q4
$1.27M Buy
137,560
+124,310
+938% +$1.14M ﹤0.01% 1504
2017
Q3
$107K Sell
13,250
-1,509
-10% -$12.2K ﹤0.01% 2679
2017
Q2
$85K Buy
+14,759
New +$85K ﹤0.01% 2838
2016
Q4
Sell
-11,500
Closed -$22K 4037
2016
Q3
$22K Buy
+11,500
New +$22K ﹤0.01% 3013
2016
Q2
Sell
-1,300
Closed -$1K 3918
2016
Q1
$1K Buy
+1,300
New +$1K ﹤0.01% 3350
2014
Q4
Sell
-2,400
Closed -$14K 4373
2014
Q3
$14K Buy
+2,400
New +$14K ﹤0.01% 3590